<p>The prognostic value and mechanisms of lncRNA UCA1 in human cancer</p>

Citations Over TimeTop 10% of 2019 papers

Abstract

Long noncoding RNAs (lncRNAs), longer than 200 nucleotides in length, play important roles in the development and progression of various cancers. An increasing number of studies have revealed that lncRNAs function as potential oncogenes or tumor suppressors to influence biological processes, such as cell growth, invasion, migration and apoptosis. Urothelial carcinoma associated 1 (UCA1), an oncogenic lncRNA, was first found in bladder cancer and highly expressed in multiple cancers, including gastric cancer, colorectal cancer, lung cancer and breast cancer. UCA1 promotes tumorigenesis mainly via binding to tumor-suppressive microRNAs (miRNAs), activating several pivotal signaling pathways and alteration of epigenetic and transcriptional regulation. In addition, high expression of UCA1 is related to poor clinicopathological features especially for shorter overall survival, suggesting that UCA1 might be regarded as a prognosis biomarker in human cancers. In the present review, we summarized current studies on UCA1 to explore its prognostic value and underlying regulation mechanisms in the development of multiple cancers in order to provide a glimmer of hope for the prevention and treatment of malignant tumors.

Related Papers

• → Mouse Models of Epigenetic Inheritance(2010)35 cited
• → The EDCs as epigenetic disruptors: Implications for development and health(2023)3 cited
• → Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders(2012)28 cited
• → Epigenetic Modifiers as Game Changers for Healthy Aging(2023)8 cited
• → Epigenetic Responses to Diet in Aging(2016)1 cited